NCT01693731|CompletedDMC
Loading search results
Sponsor study identifier
Secondary identifiers
NIH
OTHER · UM MEDIRB
observational
300
1 country
1
Study Start
April 2012
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
March 2015
Actual (reported)Study Completion
March 2015
Actual (reported)The purpose of this study is to determine how aromatase inhibitors (AIs) such as Arimidex, Aromasin or Femara affect a woman's oral health and oral health related quality of life. Patients, dental professionals and medical oncologists will benefit from a greater understanding of the best oral care follow up practices of breast cancer survivors using aromatase inhibitors.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
March 2015
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
April 2012
Date type not reportedThis date has not been verified as actual or estimated.
September 18, 2012
Actual (reported)September 26, 2012
Actual (reported)March 2015
Actual (reported)March 2015
Actual (reported)Periodontal diseases
At the time of study visit
Alveolar bone loss using salivary and serum-derived bone markers.
At the time of study visit
Oral Health Related Quality of Life (OHRQoL) assessed via questionnaire
At the time of study visit
Postmenopausal women with breast cancer taking Arimidex, Aromasin, or Femara
Healthy volunteer postmenopausal women not taking Aromatase Inhibitors
This study will have a sample of 300 postmenopausal women; 150 healthy women and 150 with early breast cancer using Aromatase Inhibitors
Michigan Center For Oral Health Research (MCOHR)
Ann Arbor, Michigan, 48106, United States
Each patient will have 5ml of blood collected at the visit. Saliva, and urine will also be collected at the study visit.
L. Susan Taichman, RDH MPH PhD
University of Michigan
300 participants (actual enrollment reported by the registry).
First Submitted
September 18, 2012
First Posted
September 26, 2012
Study Start
April 2012
Date type not reportedThis date has not been verified as actual or estimated.
The Importance of Periostin in Periodontal Health and Disease
Contact the study team to confirm eligibility.
Primary Completion
March 2015
Actual (reported)Study Completion
March 2015
Actual (reported)Last Updated
May 20, 2015
Record last verified: 2015-05
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: